Targeting ceramide metabolism in obesity
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Obesity is a major health concern that increases the risk for insulin resistance, type 2 diabetes (T2D), and cardiovascular disease. Thus, an enormous research effort has been invested into understanding how obesity-associated dyslipidemia and obesity-induced alterations in lipid metabolism increase the risk for these diseases. Accordingly, it has been proposed that the accumulation of lipid metabolites in organs such as the liver, skeletal muscle, and heart is critical to these obesity-induced pathologies. Ceramide is one such lipid metabolite that accumulates in tissues in response to obesity, and both pharmacological and genetic strategies that reduce tissue ceramide levels yield salutary actions on overall metabolic health. We will review herein why ceramide accumulates in tissues during obesity and how an increase in intracellular ceramide impacts cellular signaling and function as well as potential mechanisms by which reducing intracellular ceramide levels improves insulin resistance, T2D, atherosclerosis, and heart failure. Because a reduction in skeletal muscle ceramide levels is frequently associated with improvements in insulin sensitivity in humans, the beneficial findings reported for reducing ceramides in preclinical studies may have clinical application in humans. Therefore, modulating ceramide metabolism may be a novel, exciting target for preventing and/or treating obesity-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294 · cited 19×
“2) may also represent potential novel targets for the prevention and/or reversal of obesity-induced insulin resistance and T2D.”
BackgroundInfluentialProgrammed Cell Death Induced by Ceramide
Obeid, L. M., Linardic, C. M., Karolak, L. A., & Hannun, Y. A. (1993) · Science · doi:10.1126/science.8456305 · Cited by 1,794
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232 · cited 3×
“In this study, the authors treated Sprague-Dawley rats with myriocin (300 g/kg) prior to administering dexamethasone and observed a marked reduction in both serum and hepatic ceramide content, which was associated with decreased hepatic glucose output and an improved glucose infusion rate, suggesting that an elevation…”
BackgroundMethodGoodpaster, B. H. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5755 · Cited by 1,194
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892
Obesity and diabetes: the increased risk of cancer and cancer-related mortality
Gallagher, E. J., & LeRoith, D. (2015) · Physiological Reviews · doi:10.1152/physrev.00030.2014 · Cited by 806 · cited 1×
“Since obesity increases the risk for cancer (37), enhancing cell survival by lowering ceramide content may perpetuate cancer risk in these same individuals, as many types of cancers are due to dysregulation in the control of cellular apoptosis and proliferation (72, 106).”
BackgroundHolland, W. L., Bikman, B. T., Wang, L.-P., Yuguang, G., Sargent, K. M., Bulchand, S., Knotts, T. A., Shui, G., Clegg, D. J., Wenk, M. R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43378 · Cited by 705 · cited 3×
“(114) have demonstrated that the chronic low-grade inflammation associated with obesity also leads to increased ceramide accumulation in the liver and skeletal muscle, as infusion of lard oil into mice increased ceramide content in these tissues (50) but failed to do so in mice deficient for Toll-like receptor 4 (TLR4…”
BackgroundChavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212307200 · Cited by 617 · cited 5×
“Subsequent studies indicated that an increase in cellular ceramide content disturbs cellular glucose metabolism primarily through the inhibition of Akt [also known as protein kinase B (PKB)] (45, 105), a serine/threonine kinase that is essential for insulin signaling and insulin-mediated stimulation of glucose metabol…”
BackgroundInfluentialSchmitz-Peiffer, C., Craig, D. L., & Biden, T. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24202 · Cited by 592
Enhanced insulin sensitivity in mice lacking ganglioside GM3
Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0635898100 · Cited by 531
Peraldi, P., Hotamisligil, G. S., Buurman, W. A., White, M. F., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13018 · Cited by 412 · cited 1×
“The inflammation associated with obesity may also contribute to increased ceramide accumulation through activation of the sphingomyelin hydrolysis pathway, as inflammatory cytokines such as tumor necrosis factor- (TNF ), which are frequently elevated in the circulation of obese and insulin-resistant individuals (78, 1…”
BackgroundRegulation of Insulin Action by Ceramide
Stratford, S., Hoehn, K. L., Liu, F., & Summers, S. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406499200 · Cited by 410
Schenk, S., & Horowitz, J. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30566 · Cited by 407 · cited 1×
“As such, an acute bout of exercise (65% peak V̇O2 reached via 45 min on a treadmill followed by 45 min cycling) in nonobese women leads to marked improvements in whole body insulin sensitivity, which is associated with significant reductions in both skeletal muscle DAG and ceramide content (95).”
BackgroundSkeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance
Amati, F., Dubé, J. J., Alvarez-Carnero, E., Edreira, M. M., Chomentowski, P., Coen, P. M., Switzer, G. E., Bickel, P. E., Stefanovic-Racic, M., Toledo, F. G. S., et al. (2011) · Diabetes · doi:10.2337/db10-1221 · Cited by 395
Dubé, J. J., Amati, F., Stefanovic-Racic, M., Toledo, F. G. S., Sauers, S. E., & Goodpaster, B. H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00769.2007 · Cited by 378 · cited 1×
“Moreover, a 16-wk progressive exercise training program (75% of heart rate achieved primarily via stationary cycling, 45-min sessions 4 times/wk) in sedentary overweight or obese men and women also produces marked improvements in whole body insulin sensitivity that are associated with a lowering of skeletal muscle DAG…”
BackgroundLipid-Induced Mitochondrial Stress and Insulin Action in Muscle
Muoio, D. M., & Neufer, P. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.010 · Cited by 343 · cited 18×
“2) may also represent potential novel targets for the prevention and/or reversal of obesity-induced insulin resistance and T2D.”
BackgroundInfluentialTLR4 at the Crossroads of Nutrients, Gut Microbiota, and Metabolic Inflammation
Velloso, L. A., Folli, F., & Saad, M. J. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1100 · Cited by 337
POWELL, D. J., TURBAN, S., GRAY, A., HAJDUCH, E., & HUNDAL, H. S. (2004) · Biochemical Journal · doi:10.1042/bj20040139 · Cited by 267 · cited 2×
“This PKC -induced Akt Thr(34) phosphorylation interferes with Akt’s ability to bind membrane phosphoinositides and be phosphorylated/activated by upstream kinases (89, 90).”
BackgroundCeramide Interaction with the Respiratory Chain of Heart Mitochondria
Di Paola, M., Cocco, T., & Lorusso, M. (2000) · Biochemistry · doi:10.1021/bi9924415 · Cited by 262
Role of intramyocelluar lipids in human health
Coen, P. M., & Goodpaster, B. H. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.009 · Cited by 252 · cited 2×
“Furthermore, these observations in animals appear to be translationally relevant to humans, as skeletal muscle biopsies from obese insulin-resistant humans and/or patients with T2D also demonstrate an elevation in ceramide content that inversely correlates with their overall insulin sensitivity (23).”
BackgroundAdiponectin, driver or passenger on the road to insulin sensitivity?
Ye, R., & Scherer, P. E. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.04.001 · Cited by 251 · cited 1×
“Adiponectin is an important adipokine whose levels are inversely associated with overall adiposity, and treatment with adiponectin produces robust improvements in glucose homeostasis and overall metabolic health in experimental models of obesity (121).”
BackgroundDelpy, E. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00142-x · Cited by 94 · cited 1×
“Increased ceramide-mediated cardiac myocyte apoptosis may also contribute to the heart failure associated with doxorubicin treatment (28), an effective anticancer agent with significant dose-limiting cardiac toxicities.”
BackgroundMitochondrial fission mediates ceramide-induced metabolic disruption in skeletal muscle
Smith, M. E., Tippetts, T. S., Brassfield, E. S., Tucker, B. J., Ockey, A., Swensen, A. C., Anthonymuthu, T. S., Washburn, T. D., Kane, D. A., Prince, J. T., et al. (2013) · Biochemical Journal · doi:10.1042/bj20130807 · Cited by 87 · cited 4×
“Recent studies have also suggested that ceramide-mediated mitochondrial dysfunction involves mitochondrial fission, as treatment of C2C12 myotubes with C2 ceramide (40 M) increased mitochondrial fission, as detected with MitoTracker Red-mediated visualization of mitochondria via confocal microscopy (102).”
BackgroundInfluential
Cited by
Metabolites as regulators of insulin sensitivity and metabolism
Yang, Q., Vijayakumar, A., & Kahn, B. B. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0044-8 · Cited by 663
Roles of diacylglycerols and ceramides in hepatic insulin resistance
Petersen, M. C., & Shulman, G. I. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.004 · Cited by 373
Hepowit, N. L., Moon, B., Ebert, A. C., Dickson, R. C., & MacGurn, J. A. (2023) · Journal of Cell Science · doi:10.1242/jcs.260675 · Cited by 18
Chung, J. O., Koutsari, C., Blachnio-Zablieska, A. U., Hames, K. C., & Jensen, M. D. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00153.2017 · Cited by 8
“It is reasonably well established that FFA oversupply can lead to greater intramyocellular ceramides (1).”
Background
Metadata
- Authors
- Aburasayn, H., Al Batran, R., & Ussher, J. R.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2016-08-01
- Volume
- 311
- Issue
- 2
- Pages
- E423-E435
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2462636387
- Cited by
- 96
- References
- 24
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.